Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors

Sefidgar, Mostafa; Soltani, Madjid; Raahemifar, Kaamran; Bazmara, Hossein; Mousavi Nayinian, Seyed Mojtaba; Bazargan, Majid
July 2014
Journal of Biological Engineering;2014, Vol. 8 Issue 1, p2
Academic Journal
Background The computational methods provide condition for investigation related to the process of drug delivery, such as convection and diffusion of drug in extracellular matrices, drug extravasation from microvessels or to lymphatic vessels. The information of this process clarifies the mechanisms of drug delivery from the injection site to absorption by a solid tumor. In this study, an advanced numerical method is used to solve fluid flow and solute transport equations simultaneously to investigate the effect of tumor shape and size on drug delivery to solid tumor. Methods The advanced mathematical model used in our previous work is further developed by adding solute transport equation to the governing equations. After applying appropriate boundary and initial conditions on tumor and surrounding tissue geometry, the element-based finite volume method is used for solving governing equations of drug delivery in solid tumor. Also, the effects of size and shape of tumor and some of tissue transport parameters such as effective pressure and hydraulic conductivity on interstitial fluid flow and drug delivery are investigated. Results Sensitivity analysis shows that drug delivery in prolate shape is significantly better than other tumor shapes. Considering size effect, increasing tumor size decreases drug concentration in interstitial fluid. This study shows that dependency of drug concentration in interstitial fluid to osmotic and intravascular pressure is negligible. Conclusions This study shows that among diffusion and convection mechanisms of drug transport, diffusion is dominant in most different tumor shapes and sizes. In tumors in which the convection has considerable effect, the drug concentration is larger than that of other tumors at the same time post injection.


Related Articles

  • Bursting bubbles to treat cancer.  // TCE: The Chemical Engineer;Jul/Aug2010, Issue 829/830, p20 

    The article presents a study on the development of small bubbles that can be burst via ultrasound as a targeted method for delivering toxic drugs to tumors.

  • Stochastic Modeling of Blood Glucose Levels in Type-2 Dibetes Mellitus. Rao, P. Tirupathi; Rao, K. Srinivasa; Usha, C. L. // Asian Journal of Mathematics & Statistics;Mar2011, Vol. 4 Issue 1, p56 

    In this study we develop and analyze a stochastic model for blood glucose levels in type-2 diabetes mellitus patients. The optimal control policies of glucose regulatory system are derived. The sensitivity of the model with respect to the parameters is discussed. This model is useful for optimal...

  • Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches. Read, Tracy-Ann; Thorsen, Frits; Bjerkvig, Rolf // Current Pharmaceutical Biotechnology;Sep2002, Vol. 3 Issue 3, p257 

    Despite advances in neuro-imaging, neurosurgery, radiation therapy, and chemotherapy, limited progress has been made in the treatment of patients with high-grade astrocytomas. Primary brain tumours are considered to be among the most difficult neoplasms to treat which is largely due to the...

  • Biodegradable Polymers as Matrices for Control Drug Delivery. Mucha, Maria; Socha-Michalak, Iwona; Balcerzak, Jacek // Advanced Materials Research;2014, Issue 911, p336 

    In the paper the results of control drug release from different forms of carriers are presented. Dibutyrylchitin, chitosan, polylactid acid and polycaprolactone have been used as matrices for delivery of therapeutic substances (ibuprofen and salicylic acid). Two configurations of matrices for...

  • Armed with Peptides, Drug Developers Aim for Tumors. Dove, Alan // Drug Discovery & Development;Mar2012, Vol. 15 Issue 3, p10 

    The article discusses that researchers are looking for different strategies to deliver drugs specifically for tumors. It is mentioned that scientists are looking for tumor-targeting peptides, contract research organizations (CRO) and other service companies are increasingly catering to this...

  • Inovio Halts Pivotal Program Of Tumor Ablation Therapy. Lorenzo, Aaron // BioWorld Today;6/6/2007, Vol. 18 Issue 109, p1 

    The article focuses on the decision of Inovio Biomedical Corp. to hold a pivotal program for its Selective Electrochemical Tumor Ablation (SECTA) therapy. It was noted that Inovio stopped the trials over concerns about efficacy and higher mortality rates in patients receiving the therapy....

  • pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study. Silva, Juliana; Fernandes, Renata; Lopes, Sávia; Cardoso, Valbert; Leite, Elaine; Cassali, Geovanni; Marzola, Maria; Rubello, Domenico; Oliveira, Monica; Barros, Andre; Silva, Juliana O; Fernandes, Renata S; Lopes, Sávia C A; Cardoso, Valbert N; Leite, Elaine A; Cassali, Geovanni D; Marzola, Maria Cristina; Oliveira, Monica C; de Barros, Andre Luis Branco // Molecular Imaging & Biology;Dec2016, Vol. 18 Issue 6, p898 

    Purpose: Therapeutic agents used in chemotherapy have low specificity leading to undesired severe side effects. Hence, the development of drug delivery systems that improve drug specificity, such as liposome moieties, is an alternative to overcome chemotherapy limitations and...

  • Selective Photothermal Tumor Therapy Using Nanodiamond-Based Nanoclusters with Folic Acid. Ryu, Tae‐Kyung; Baek, Seung Woon; Kang, Rae Hyung; Choi, Sung‐Wook // Advanced Functional Materials;9/20/2016, Vol. 26 Issue 35, p6428 

    This paper describes the fabrication and evaluation of folic acid (FA)-conjugated nanodiamond (ND) nanoclusters for selective photothermal tumor therapy. ND nanoclusters with surface carboxyl groups are aminated using ethylenediamine and conjugated with FA via carbodiimide chemistry. The...

  • Hyaluronic acid coated hollow mesoporous silica nanoparticles for reduction-triggered drug release. Yuanyuan Zhang; Xiang Cao; Shengke Xiang; Zhiwei Tong // Micro & Nano Letters;2018, Vol. 13 Issue 11, p1550 

    In this work, the reduction-responsive hyaluronic acid (HA) coated hollow mesoporous silica nanoparticles (HMSNs) were developed for the targeted tumour therapy. First, the anticancer drug doxorubicin was retained inside the central hollow cavities of the HMSNs with high loading efficiency....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics